Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Subcontract opportunity from Department Of Defense was posted on July 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Pharmaceutical Supply – Nirmatrelvir and Ritonavir (Paxlovid)

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--Request for Information (RFI) - Specialty – PPV 2028 Amendment 0002 to Extend Response Date from Nov. 16, 2026 to Nov. 30, 2026 at 11AM CT
Solicitation # 36E79727Q0001
The Department of Veterans Affairs, through the OALC Enterprise Procurement Office, has issued a Request for Information regarding the Pharmaceutical Prime Vendor (PPV) 2028 program. The agency is seeking market research to determine the feasibility of integrating Limited Distribution and Closed Distribution Products (CDP) into the PPV scope. These specialty medications are typically high-cost, low-volume items with restricted distribution channels that often require specific clinical justifications, manufacturer-mandated registrations, and specialized safety monitoring. The primary objective is to establish a seamless ordering platform where all Federal Supply Schedule (FSS) items, including those that bypass the physical possession of the prime vendor, are visible and orderable with accurate invoicing and delivery tracking for VA medical centers nationwide. The government is soliciting detailed feedback from industry partners on their ability to coordinate fulfillment with manufacturer-designated specialty distributors and their capacity to provide consistent reporting and reconciliation for these transactions. Potential respondents must provide their company name, point of contact information, UEI, CAGE code, and any applicable socioeconomic designations. Submissions are due by 11 AM Central on November 16, 2026, via email to Karen Ade. This notice is strictly for market research purposes and does not constitute a formal solicitation or a commitment by the government to award a contract.
Nac Prime Vendor (36W797)

POSTED

about 23 hours ago

DEADLINE

in 20 days

AI Contract Overview

Show more

The contract involves the supply of one box of Pfizer’s Nirmatrelvir and Ritonavir tablets, identified by NDC 00069-5321-30 and commonly known as Paxlovid, for the treatment of COVID-19. This order is governed by federal medical supply chain and defense logistics standards, necessitating strict adherence to procurement protocols, quality control, and distribution requirements applicable to Department of Defense medical resources. The item must be delivered in full compliance with regulatory and logistical frameworks ensuring integrity, traceability, and readiness for deployment in military or federally supported healthcare environments. Issued under the NAICS code 325412 for pharmaceutical preparation manufacturing, the contract was posted on July 13, 2026, with a response deadline of July 16, 2026, and is classified as a subcontract within the Medical Supply Chain Pharm FSA framework managed by the Department of Defense. The place of performance is designated as FPO with ZIP code 96661, indicating delivery to a military postal address, likely for use in overseas or remote service locations. All bidders are expected to meet defense-specific documentation, packaging, and shipping criteria to support timely and secure access to this critical antiviral therapy within the military health system.

General Info

One box of Paxlovid supplied per DoD medical logistics standards to FPO 96661 by July 16, 2026.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

FPO, AP, 96661, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-26-T-3985.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

NIRMATRELVIR AND RI

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of one box of Pfizer's Nirmatrelvir and Ritonavir tablets (NDC 00069-5321-30), known as Paxlovid, for treatment of COVID-19, requiring compliance with federal medical supply chain and defense logistics standards.

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS